Fig. 2From: Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosisBody temperature of patients (P8–11). Body temperature returned to normal after 3 days of ruxolitinib treatmentBack to article page